Valeant Pharmaceutic
VRX
Delayed Toronto Stock Exchange - 05/24 09:14:42 pm
28.6CAD
+0.7%
Prev.28.4000
Open28.4200
High28.7400
Low28.2600
Volume584 673
Financials
Sales 2018 8 508 M
EBIT 2018 3 067 M
R. net 2018 -3 544 M
Debt 2018 23 708 M
Rend. 2018 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales 2018 3,69x
EV / Sales 2019 3,59x
Capitalization 7 719 M
Company
Valeant Pharmaceuticals International, Inc. engages in the development, manufacture, and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products.It operates through the following segments: The Bausch + Lomb/International, Branded Rx,...
Sector :
Pharmaceuticals - NEC
Calendar :
2018-08-07 Earnings Release
Trading Rating :
Investor Rating :
Latest news
12:20aWILLIAM ACKMAN : Ackman makes roughly $1 billion bet on Lowe's
RE
05/23VALEANT PHARMACEUTICALS INTL : Ex-Valeant Executive Convicted In Scheme -- WSJ
DJ
05/22VALEANT PHARMACEUTICALS INTL : Ex-Valeant, Philidor executives convicted of kickback scheme
RE
05/22VALEANT PHARMACEUTICALS INTL : Former Valeant Executive Found Guilty on Charges Related to Kickback Scheme
DJ
05/22VALEANT PHARMACEUTICALS INTL : Former Valeant Executive And Former Philidor Ceo Convicted For Illegal Kickback Scheme
AQ
05/21VALEANT PHARMACEUTICALS INTL : Announces Launch Of Private Offering Of Notes And Upsize Of Term Loans
AQ
05/21VALEANT PHARMACEUTICALS INTL : Announces Pricing Of Private Offering Of Notes
AQ
05/17VALEANT PHARMACEUTICALS INTL : Will Become Bausch Health Companies Inc.
AQ
Technical analysis trends
Short TermMid-TermLong Term
TrendBullishNeutralNeutral
Resistance28,530,329,7
Spread/Res.0,21%-5,6%-3,8%
Spread/Supp.12%49%95%
Support25,619,214,6